NCT04425070 2026-01-05
TOUCH
Antengene Corporation
Phase 1/2 Terminated
Clinical Trials
3 trialsNCT04948788 2021-09-28
SHR1459 in Combination With YY-20394 in Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown
NCT00169195 2015-09-02
Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma
Lymphoma Study Association
Phase 2 Completed